TY - JOUR
T1 - Standardising definitions for the pre-eclampsia core outcome set
T2 - A consensus development study
AU - International Collaboration to Harmonise Outcomes for Preeclampsia (iHOPE)
AU - Duffy, James M.N.
AU - Cairns, Alexandra E.
AU - Magee, Laura A.
AU - von Dadelszen, Peter
AU - van 't Hooft, Janneke
AU - Gale, Chris
AU - Brown, Mark
AU - Chappell, Lucy C.
AU - Grobman, William A.
AU - Fitzpatrick, Ray
AU - Karumanchi, S. Ananth
AU - Lucas, D. Nuala
AU - Mol, Ben
AU - Stark, Michael
AU - Thangaratinam, Shakila
AU - Wilson, Mathew J.
AU - Williamson, Paula R.
AU - Ziebland, Sue
AU - McManus, Richard J.
AU - Abalos, Edgardo J.
AU - Adamson, Christine C.D.
AU - Akadri, Adebayo A.
AU - Akturk, Zekeriya
AU - Allegaert, Karel
AU - Angel-Müller, Edith
AU - Antretter, Jessica
AU - Ashdown, Helen F.
AU - Audibert, Francois
AU - Auger, Nathalie
AU - Aygun, Canan
AU - Babic, Inas
AU - Bagga, Rashmi
AU - Baker, Judith M.
AU - Beebeejaun, Yusuf
AU - Bhakta, Pradipta
AU - Bhandari, Vineet
AU - Bhattacharya, Sohinee
AU - Blanker, Marco H.
AU - Bloomfield, Frank H.
AU - Bof, Anna
AU - Brennan, Siobhan M.
AU - Broekhuijsen, Kim
AU - Broughton Pipkin, Fiona
AU - Browne, Joyce L.
AU - Browning, Roger M.
AU - Bull, Jameson W.
AU - Butt, Amina
AU - Button, Dena
AU - Campbell, Jeremy P.
AU - Campbell, Doris M.
N1 - Funding Information:
Dr Gale has received expenses to attend an educational conference from Chiesi Pharmaceuticals and his institution has received research funding from Chiesi Pharmaceuticals. Prof Karumanchi reports serving as a consultant to Roche and Thermofisher Scientific and has a financial interest in Aggamin Pharmaceuticals. Prof Mol is a consultant for ObsEva. The remaining authors declare no competing interests.
Funding Information:
This paper reports independent research arising from a doctoral fellowship (DRF-2014-07-051) supported by the National Institute for Health Research. Dr Chris Gale was supported by a Medical Research Council Clinician Scientist Fellowship . Prof Richard McManus was supported by a National Institute for Health Research Professorship (NIHR-RP-R2-12-015) and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Oxford. Prof Mol is supported by a National Health and Medical Research Practitioner Fellowship (GNT1082548). Prof Richard McManus, Prof Paula Williamson, and Prof Sue Ziebland are supported by National Institute for Health Research Senior Investigator awards. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.
Funding Information:
This paper reports independent research arising from a doctoral fellowship (DRF-2014-07-051) supported by the National Institute for Health Research. Dr Chris Gale was supported by a Medical Research Council Clinician Scientist Fellowship. Prof Richard McManus was supported by a National Institute for Health Research Professorship (NIHR-RP-R2-12-015) and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Oxford. Prof Mol is supported by a National Health and Medical Research Practitioner Fellowship (GNT1082548). Prof Richard McManus, Prof Paula Williamson, and Prof Sue Ziebland are supported by National Institute for Health Research Senior Investigator awards. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health. We would like to thank the healthcare professionals and researchers who participated in the consensus development meeting. We would like to thank the Radcliffe Women's Health Patient Participation group, Action on Pre-eclampsia, and our patient and public representatives who assisted with study design, data interpretation, and planned dissemination. We would like to thank colleagues at the Nuffield Department of Primary Care Health Sciences, University of Oxford including Jacqui Belcher, Carla Betts, Lucy Curtin, Dawn Evans, Caroline Jordan, Sarah King, Sam Monaghan, Dan Richards-Doran, Nicola Small, and Clare Wickings for administrative, technical, or material support. We would like to thank Prof. Marian Knight, Nuffield Department of Population Health, University of Oxford, for providing subject-specific expertise. We would like to thank colleagues at the Women's Health Research Unit, Queen Mary, University of London including Prof. Khalid Khan, Tracy Holtham, and Rehan Khan for administrative, technical support, or subject-specific expertise.
Funding Information:
This study was funded by the Balliol College, University of Oxford, Barts Charity, Elizabeth Garrett Anderson Hospital Charity, Royal College of Obstetricians and Gynaecologists, and National Institute for Health Research. The funders have no role in the design and conduct of the study, the collection, management, analysis, or interpretation of data, or manuscript preparation.
Publisher Copyright:
© 2020 International Society for the Study of Hypertension in Pregnancy
PY - 2020/7
Y1 - 2020/7
N2 - Objectives: To develop consensus definitions for the core outcome set for pre-eclampsia. Study design: Potential definitions for individual core outcomes were identified across four formal definition development initiatives, nine national and international guidelines, 12 Cochrane systematic reviews, and 79 randomised trials. Eighty-six definitions were entered into the consensus development meeting. Ten healthcare professionals and three researchers, including six participants who had experience of conducting research in low- and middle-income countries, participated in the consensus development process. The final core outcome set was approved by an international steering group. Results: Consensus definitions were developed for all core outcomes. When considering stroke, pulmonary oedema, acute kidney injury, raised liver enzymes, low platelets, birth weight, and neonatal seizures, consensus definitions were developed specifically for low- and middle-income countries because of the limited availability of diagnostic interventions including computerised tomography, chest x-ray, laboratory tests, equipment, and electroencephalogram monitoring. Conclusions: Consensus on measurements for the pre-eclampsia core outcome set will help to ensure consistency across future randomised trials and systematic reviews. Such standardization should make research evidence more accessible and facilitate the translation of research into clinical practice. Video abstract can be available at: www.dropbox.com/s/ftrgvrfu0u9glqd/6.%20Standardising%20definitions%20in%20teh%20pre-eclampsia%20core%20outcome%20set%3A%20a%20consensus%20development%20study.mp4?dl=0.
AB - Objectives: To develop consensus definitions for the core outcome set for pre-eclampsia. Study design: Potential definitions for individual core outcomes were identified across four formal definition development initiatives, nine national and international guidelines, 12 Cochrane systematic reviews, and 79 randomised trials. Eighty-six definitions were entered into the consensus development meeting. Ten healthcare professionals and three researchers, including six participants who had experience of conducting research in low- and middle-income countries, participated in the consensus development process. The final core outcome set was approved by an international steering group. Results: Consensus definitions were developed for all core outcomes. When considering stroke, pulmonary oedema, acute kidney injury, raised liver enzymes, low platelets, birth weight, and neonatal seizures, consensus definitions were developed specifically for low- and middle-income countries because of the limited availability of diagnostic interventions including computerised tomography, chest x-ray, laboratory tests, equipment, and electroencephalogram monitoring. Conclusions: Consensus on measurements for the pre-eclampsia core outcome set will help to ensure consistency across future randomised trials and systematic reviews. Such standardization should make research evidence more accessible and facilitate the translation of research into clinical practice. Video abstract can be available at: www.dropbox.com/s/ftrgvrfu0u9glqd/6.%20Standardising%20definitions%20in%20teh%20pre-eclampsia%20core%20outcome%20set%3A%20a%20consensus%20development%20study.mp4?dl=0.
KW - Consensus development study
KW - Core outcome set
KW - Hypertension in pregnancy
KW - Outcome measure
KW - Pre-eclampsia
KW - Randomised controlled trials
UR - http://www.scopus.com/inward/record.url?scp=85087746870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087746870&partnerID=8YFLogxK
U2 - 10.1016/j.preghy.2020.06.005
DO - 10.1016/j.preghy.2020.06.005
M3 - Article
C2 - 32674052
AN - SCOPUS:85087746870
SN - 2210-7789
VL - 21
SP - 208
EP - 217
JO - Pregnancy Hypertension
JF - Pregnancy Hypertension
ER -